Recruitment

Recruitment Status
Completed
Estimated Enrollment
22

Summary

Conditions
Healthy
Type
Interventional
Phase
Phase 4
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Basic Science

Participation Requirements

Age
Between 21 years and 40 years
Gender
Both males and females

Description

The objective of this study is to identify the network transformations that account for the analgesic effects of nitrous oxide. Our hypothesis is that analgesic doses of nitrous oxide increase network efficiency and disrupt normal pain processingOur approach is to administer subanesthetic nitrous ox...

The objective of this study is to identify the network transformations that account for the analgesic effects of nitrous oxide. Our hypothesis is that analgesic doses of nitrous oxide increase network efficiency and disrupt normal pain processingOur approach is to administer subanesthetic nitrous oxide during the acquisition of fMRI (functional magnetic resonance imaging) and EEG (electroencephalogram).

Tracking Information

NCT #
NCT03435055
Collaborators
Not Provided
Investigators
Principal Investigator: Richard Harris, PhD Associate Professor of Anesthesiology and Associate Professor of Internal Medicine